CURRENT ISSUE Current Issue Cover
VOL 8 • NO 6 SEP/OCT 2017
IN THIS ISSUE

Breast Implants and Lymphoma: What Is the Risk for Your Patient?

Pamela Hallquist Viale, RN, MS, CNS, ANP

Assessing the Plain Language Planner for Communication About Common Palliative Care Medications

Elaine Wittenberg,(1) PhD, Betty Ferrell,(2) RN, PhD, MA, FAAN, FPCN, CHPN, and Joy Goldsmith,(3) PhD


Managing Drug Interactions in Cancer Therapy: A Guide for the Advanced Practitioner

Christopher J. Campen,(1) PharmD, BCOP, Wendy H. Vogel,(2) MSN, FNP, AOCNP®, and Pooja J. Shah,(3) PharmD, BCPS

 
Section Seperator

TODAY'S NEWS

IASLC 2017: Race, Socioeconomic Factors ...

New research presented at the International Associ...

IASLC 2017: Lorlatinib in ALK-Positive a...

At the International Association for the Study of ...

IASLC 2017: CheckMate-032: Nivolumab Alo...

At the International Association for the Study of ...

FDA Grants Priority Review for Cabozanti...

On October 16, the U.S. Food and Drug Administrati...

Immunotherapy for Previously Treated Adv...

In an Asian phase III trial reported in The Lancet...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

Brentuximab Vedotin Infusion Reaction

Infusion reactions have been reported with brentuximab vedotin therapy in both clinical trial settings and in the post clinical trial experience...

Patients Receiving Inotuzumab Ozogamicin

Successfully conducting oncology clinical trials requires the involvement of various research personnel...

Screening for Cancer w/Prostate-Specific Antigen

Prostate cancer is the second-leading cause of cancer death in male Americans, behind only lung cancer...

Venetoclax for Patients With del(17p) CLL

Chronic lymphocytic leukemia (CLL) is a hematologic malignancy characterized by abnormal numbers of mature B lymphocytes...

The Oncology Care Model for APs

The Centers for Medicare & Medicaid Services (CMS) Oncology Care Model (OCM) is a new, multipayer model that focuses on higher quality, coordinated oncology care...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

Long-Term Use of Long-Acting Insulin Ana...

A study in the UK population has shown that long-t...

IASLC 2017: Early Palliative Care Provid...

Early specialist palliative care for patients who ...

IASLC 2017: Brigatinib in ALK-Positive N...

Data from the phase II ALTA clinical trial evaluat...

IASLC 2017: Combination of Lurbinectedin...

The final efficacy and safety data obtained from a...

Maintenance Therapy After ASCT in Younge...

In a French phase III trial, maintenance rituximab...

More Highlights More Highlights
 
Section Seperator
Section Seperator
 
 
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me